Fibrobiologics, INC. (FBLG) SEC Filings — 2024
29 SEC filings for Fibrobiologics, INC. (FBLG) in 2024.
Filings
- FibroBiologics Files 8-K: Agreements, Equity, and Personnel Changes — 8-K · Dec 31, 2024
- FibroBiologics Files S-1 for Public Offering — S-1 · Dec 30, 2024
- FibroBiologics Files 8-K: Agreements, Obligations, and Equity Sales — 8-K · Dec 23, 2024
- FibroBiologics Files 8-K: Agreements, Equity Sales — 8-K · Dec 20, 2024
- FibroBiologics Files Q3 2024 10-Q — 10-Q · Nov 12, 2024
- FibroBiologics Board Shake-up: New Director Elected, Officer Compensation Noted — 8-K · Oct 29, 2024
- FibroBiologics, Inc. Enters Material Definitive Agreement — 8-K · Sep 24, 2024
- FibroBiologics Files 8-K on Corporate Actions — 8-K · Aug 28, 2024
- FibroBiologics Files 8-K for Equity Sale — 8-K · Aug 27, 2024
- FibroBiologics Files 10-Q, Details Preferred Stock — 10-Q · Aug 7, 2024
- FibroBiologics Files Definitive Proxy Statement — DEF 14A · Jul 8, 2024
- FibroBiologics Relocates Offices, Updates Contact Info — 8-K · Jun 27, 2024
- FibroBiologics Files S-1 for Public Offering — S-1 · Jun 18, 2024
- FibroBiologics Files S-1/A Amendment for IPO — S-1/A · Jun 4, 2024
- FibroBiologics Files Amendment to S-1 Registration Statement — S-1/A · May 15, 2024
- FibroBiologics, Inc. Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 14, 2024
- FibroBiologics Files 8-K Report — 8-K · Apr 26, 2024
- FibroBiologics Files S-1/A Amendment — S-1/A · Mar 26, 2024
- FibroBiologics, Inc. Files S-1/A Amendment — S-1/A · Mar 15, 2024
- FibroBiologics, Inc. Files 2023 Annual Report on Form 10-K — 10-K · Feb 29, 2024
- FibroBiologics Files 8-K on Other Events and Financial Exhibits — 8-K · Feb 20, 2024
- FibroBiologics Files 8-K for Unspecified Events and Exhibits — 8-K · Feb 14, 2024
- FibroBiologics, Inc. Files S-1 Registration Statement — S-1 · Feb 12, 2024
- FibroBiologics Files 8-K, Confirms Emerging Growth Status — 8-K · Feb 8, 2024
- FibroBiologics 8-K: Emerging Growth Co. Opts Out of Accounting Grace Period — 8-K · Feb 6, 2024
- FibroBiologics Confirms Emerging Growth Company Status in 8-K — 8-K · Feb 2, 2024
- FibroBiologics Inc. Files Amendment to S-1 Registration Statement — S-1/A · Jan 24, 2024
- FibroBiologics Inc. Files Amendment 6 to S-1 Registration Statement — S-1/A · Jan 22, 2024
- FibroBiologics Inc. Files Amendment No. 5 to S-1 Registration Statement — S-1/A · Jan 12, 2024